Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company specializing in RNA interference therapeutics. They have a range of products for various diseases and strategic collaborations with industry leaders for developing innovative treatments. Founded in 2002, the company is based in Cambridge, Massachusetts.